Article info

Download PDFPDF
Letter
PPIs and anti-TNF in patients with IBD: a forbidden combination?

Authors

  • Judith Wellens Gastroenterology and Hepatology, KU Leuven University Hospitals Leuven Gasthuisberg Campus, Leuven, Flanders, Belgium Gastroenterology and Hepatology, KU Leuven University Hospitals Leuven, Leuven, Flanders, Belgium PubMed articlesGoogle scholar articles
  • João Sabino Gastroenterology and Hepatology, KU Leuven University Hospitals Leuven Gasthuisberg Campus, Leuven, Flanders, Belgium Gastroenterology and Hepatology, KU Leuven University Hospitals Leuven, Leuven, Flanders, Belgium Department of Chronic Diseases Metabolism and Ageing, KU Leuven University Hospitals Leuven Campus Gasthuisberg, Leuven, Flanders, Belgium PubMed articlesGoogle scholar articles
  • Séverine Vermeire Gastroenterology and Hepatology, KU Leuven University Hospitals Leuven, Leuven, Flanders, Belgium Department of Chronic Diseases Metabolism and Ageing, KU Leuven University Hospitals Leuven Campus Gasthuisberg, Leuven, Flanders, Belgium PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Judith Wellens, Gastroenterology and Hepatology, KU Leuven University Hospitals Leuven Gasthuisberg Campus, Leuven, Flanders, Belgium; Judith.wellens{at}kuleuven.be
View Full Text

Citation

Wellens J, Sabino J, Vermeire S
PPIs and anti-TNF in patients with IBD: a forbidden combination?

Publication history

  • Received January 5, 2021
  • Revised January 20, 2021
  • Accepted January 22, 2021
  • First published January 29, 2021.
Online issue publication 
November 08, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.